Skip to content

Clinical trials

Phase 1 Kidney Failure, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Failure, Chronic Phase: Phase 1 Country / region: United States Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20034
20051
20065
20073
20082
20096
20104
20112
20122
20134
20147
20156
20163
20171
20182
20194
20202
20214
20225
20235
20246
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Recruiting5
Terminated4
Active, not recruiting3
Withdrawn3
Not yet recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
Amgen4
Eli Lilly and Company4
Incyte Corporation4
Bristol-Myers Squibb3
National Institute of Allergy and Infectious Diseases (NIAID)3
Pfizer3
Akebia Therapeutics2
Dynavax Technologies Corporation2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Failure, Chronic88
Renal Insufficiency31
Renal Insufficiency, Chronic15
Kidney Diseases12
Multiple Myeloma3
Anemia2
Calciphylaxis2
Hepatitis B2
Hyperparathyroidism2
Hyperparathyroidism, Secondary2

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.